Announcements Trials
Browse Landscape

Phase

Phase 1 113Phase NA 62Phase 2 51Phase 1/2 40Phase 3 26Phase EARLY_PHASE1 10Phase 2/3 6Phase 4 4

Status

Withdrawn 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 53Classical hematology 21Genitourinary 14Gastrointestinal 13Breast 9Other hematologic neoplasm 8Thoracic 5Other 5Plasma cell 4Lymphoid 4Gynecologic 4Dermatologic 4CNS 4Sarcoma 3NET 3Endocrine 3Myeloid 2Head & Neck 2

Conditions

Brain Neoplasms 34Glioblastoma 8Glioma 7Meningeal Carcinomatosis 6Epilepsy 5Neuroblastoma 4Neoplasms 4Neoplasm Metastasis 4Pituitary Neoplasms 3Meningioma 3Melanoma 3Lung Neoplasms 3Breast Neoplasms 3Seizures 2Retinoblastoma 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Paraganglioma 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 1 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Delirium 2Central Nervous System Diseases 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Wilms Tumor 1Stroke 1

Interventions

olutasidenib 1Sevoflurane 1Radiosurgery 1Propofol 1Nitrous Oxide 1Lidocaine 1Glycopyrrolate 1Dexmedetomidine 1Cytochrome P-450 CYP3A 1Cytochrome P-450 CYP2C9 1Cytochrome P-450 CYP2C8 1Cytochrome P-450 CYP2C19 1Cytochrome P-450 CYP2B6 1Cytochrome P-450 CYP1A2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × CNS × Clear all
NCT07486713 2026-06-05

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

Rigel Pharmaceuticals

Phase 4 Recruiting
16 enrolled
CNSGastrointestinalOther hematologic neoplasm

Glioma, Neoplasms, Leukemia, Myeloid, Acute, Cholangiocarcinoma

NCT05342883 2025-09-05

GESTALT

GT Medical Technologies, Inc.

Phase 4 Active not recruiting
61 enrolled
CNS

Glioblastoma, Glioma, Neoplasms

NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn
CNS

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡